DCAT Week 2025: Gaining End-to-End Clarity

Looking at the outsourcing market more from the customer side, Henny Zijlstra, chief commercial officer for Adragos Pharma, specifies that a key trend is onshoring. European companies are shying away from Asia and India more so and are preferentially looking for goods and services based with Europe instead, she explains. In addition to onshoring, the geopolitical situation is high on the agenda, leading to more companies looking at outsourcing manufacturing in Europe versus the United States, she adds.

“I don't believe that [customer] demands have [necessarily] increased or changed,” Zijlstra continues. “I think it's more the service levels that [customers are] looking for which are different.” For service-providers, being customer focused is key, she remarks, making sure the customer is prioritized and have full transparency during their development project.

“In general, we've seen that it's not only Big Pharma looking for outsourcing [partners anymore],” Zijlstra says. “The biotechs [also] need these service levels, and they need the help to make sure that they actually get to the next phase of their development, to either secure their funding or to actually get to the patients faster. So, from that perspective, an end-to-end service, gives you the clarity.”

Click above to watch the full interview

About the speaker

Henny Zijlstra, Chief Commercial Officer of Adragos Pharma

Henny Zijlstra, Chief Commercial Officer (CCO) of Adragos Pharma, is a strategic and customer-focused leader with a Master’s in Business and a robust background in International Business. With nearly 18 years of experience in the pharmaceutical industry, she began her career in business development, sales, and product management before rising to management and more commercially focused roles.
Her career includes significant roles in sales, product management, and global business development at renowned companies such as DSM, Lonza, and Hetero Europe. Passionate about challenging conventions, Henny consistently pushes boundaries to develop forward-thinking strategies that drive growth and transformation.
As CCO, Henny leads with a compelling vision, instilling a customer-centric mindset across the organization. Her commitment to excellence and industry progress fuels Adragos Pharma’s mission to deliver impactful innovations.